Age-Related Macular Degeneration: A Disease of Cellular Senescence and Dysregulated Immune Homeostasis
Cunzi Li,Lan Zhou,Hongyan Sun,Ming Yang
DOI: https://doi.org/10.2147/cia.s463297
IF: 3.829
2024-05-24
Clinical Interventions in Aging
Abstract:Cunzi Li, 1 Lan Zhou, 2, 3 Hongyan Sun, 2 Ming Ming Yang 2 1 The Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, 518020, People's Republic of China; 2 Department of Ophthalmology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, 518020, People's Republic of China; 3 Post-Doctoral Scientific Research Station of Basic Medicine, Jinan University, Guangzhou, 510632, People's Republic of China Correspondence: Ming Ming Yang, Department of Ophthalmology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), No. 1017 Dongmen North Road, Luohu District, Shenzhen, 518020, People's Republic of China, Tel +86 22944163, Email Age-related macular degeneration (AMD) is a degenerative ocular disease primarily affecting central vision in the elderly. Its pathogenesis is complex, involving cellular senescence and immune homeostasis dysregulation. This review investigates the interaction between these two critical biological processes in AMD pathogenesis and their impact on disease progression. Initially, cellular senescence is analyzed, with particular emphasis on retinal damage induced by senescent retinal pigment epithelial cells. Subsequently, the occurrence of immune homeostasis dysregulation within the retina and its mechanistic role in AMD areis explored. Furthermore, the paper also discusses in detail the interplay between cellular senescence and immune responses, forming a vicious cycle that exacerbates retinal damage and may influence treatment outcomes. In summary, a deeper understanding of the interrelation between cellular senescence and immune dysregulation is vital for the developing innovative therapeutic strategies for AMD. Keywords: age-related macular degeneration, cellular senescence, immune homeostasis dysregulation Age-related macular degeneration (AMD) is a major cause of blindness among the elderly in developed countries, and its prevalence is escalating due to an aging global population. It is estimated that 8.69% of the global population is affected by AMD, impacting 196 million people in 2020. This prevalence is projected to increase to 288 million by 2042, significantly contributing to the global disease burden. 1 The pathogenesis of AMD is complex, involving genetics, environmental influences, metabolic processes, and lifestyle choices. 2 Recent research has highlighted the pivotal roles of cellular senescence and the dysregulation of immune homeostasis in AMD pathophysiology. Cellular senescence represents a complex biological phenomenon, extensively present within the retina. In particular, senescence of retinal pigment epithelial (RPE) cells significantly impacts the structural and functional integrity of the retina, thereby contributing to AMD progression. 3 The homeostasis of the immune system plays an essential role in maintaining tissue health. In AMD, immune homeostasis disruption is characterized by chronic low-grade inflammation, a critical factor accelerating damage to both the retina and RPE. 4 The interplay between cellular senescence and the dysregulation of immune homeostasis constitutes a critical characteristic of the pathophysiological process in AMD. In this paper, we will thoroughly examine how these two processes interact via complex molecular and cellular mechanisms, collaboratively contributing to the progression of AMD. Cellular senescence (also termed "senescence") was first proposed by Hayflick and Moorhead in 1961. It refers to irreversible cell cycle arrest during mitosis, leading to the emergence of senescent cells (SNCs). 5 SNCs play crucial roles in various biological processes, including embryonic development, tissue remodeling, wound repair, tumorigenesis, aging, and age-related diseases. 6 However, alterations in immune system function and the resistance of SNCs to apoptosis result in their accumulation, thereby triggering a range of age-related diseases, including Alzheimer's disease, osteoarthritis, pulmonary fibrosis, and AMD. 7–9 The mechanism of cellular senescence involves two tumor suppressor pathways: p16 INK4A -pRB and p53-p21 CIP1/WAF1 . These pathways inhibit the expression of cell cycle-related proteins and proliferation-promoting transcription factors, resulting in cell cycle arrest at G1 or G2 phase. 10 Although SNCs stop replicating and proliferating, they remain in a metabolically active state, accompanied by the upregulation of numerous inflammatory factors, chemokines, growth factors, etc., -Abstract Truncated-
geriatrics & gerontology,gerontology